Amy Judd Lieberman, J.D., serves as Senior Attorney, Harm Reduction Legal Project. Before joining the Network, Amy worked briefly in litigation after a fellowship with the National Health Law Program (NHeLP) working on critical issues related to the opioid epidemic and promoting harm reduction practices, specifically in the communities served by Medicaid and Medi-cal. While in law school, she was the president of the Law Students for Sensible Drug Policy chapter, spearheading efforts to educate law students and the community on humane drug policy and harm reduction. She was also an advocate on the Jessup International Moot Court team and a research editor for the UC Irvine Law Review, and she received awards for her pro bono work and her work in the International Justice Clinic, supporting the mandate of the United Nations Special Rapporteur on the promotion and protection of the right to freedom of opinion and expression. Amy received her B.F.A from New York University and her J.D. from the University of California, Irvine School of Law.  She is barred in California and the United States District Court for the Central District of California.

Articles & Resources

Harm Reduction Legal Project Resource Roundup

Law & Policy InsightsHarm Reduction Legal ProjectSubstance Use Prevention and Harm Reduction

June 16, 2021
by Amy Lieberman

Parents want to ensure the safety of their children whenever they are passengers in their vehicles by using appropriate car seats or booster seats. Every state has laws regarding child safety restraints for young children while riding in a motor vehicle. However, what happens when parents of young children travel? Rideshares, like Uber and Lyft, are an attractive way to get from the airport to a hotel or other destination. Unfortunately, the requirements around using child safety restraints in rideshares vary by state and are often vague.

Read more

Equitable Rebuilding from COVID-19: Ensuring Quality Care for Vulnerable Populations

WebinarsCOVID-19COVID-19 and Health EquityMental Health and Well-BeingOpioid Misuse and Overdose PreventionTelehealth

May 11, 2021
by Amy Lieberman, Corey Davis and Jill Krueger

In this webinar, presenters will describe the nature of the laws being announced from the judicial bench or proposed in state legislatures, the process by which they are being formulated in every level and branch of government, and the principles that should guide legal developments as we seek to balance the facts, expert opinion, and civic participation, as well as guard against harmful unforeseen consequences.

View page

Access to Treatment for Individuals with Opioid Use Disorder

GuidanceHarm Reduction Legal Project ResourcesOpioid Misuse and Overdose Prevention

April 21, 2021
by Amy Lieberman and Corey Davis

The Network has joined with public health law partners to produce a new report, COVID-19 Policy Playbook: Legal Recommendations for a Safer, More Equitable Future, examining policy challenges and opportunities in light of the pandemic. In this Q&A, the Network’s Corey Davis and Amy Lieberman discuss some of the key elements in the chapter they co-authored for the report including the positive impact of opioid use disorder (OUD) treatment, recent changes to increase access to that treatment, and recommendations for permanently reducing legislative and regulatory barriers to effective, evidence-based interventions for OUD.

View page

Ensuring Access to Clean Needles Can Save Lives, but Legal Barriers Persist

Law & Policy InsightsHarm Reduction Legal ProjectHarm Reduction Legal Project ResourcesOpioid Misuse and Overdose PreventionSubstance Use Prevention and Harm Reduction

February 5, 2021
by Amy Lieberman and Corey Davis

The United States continues to experience an unprecedented level of drug-related harm. While the failure to prevent this harm is most notable in the number of overdose deaths, which are now at their highest level on record, it is evident in other areas as well. Of particular importance from a policy perspective, bloodborne disease infections related to syringe sharing are also on the rise, with recent outbreaks in Kentucky, Massachusetts, and Indiana, among other states. Cases of infective endocarditis, which is caused largely by unsafe injection, are increasing as well.

Read more

Q&A: Access to Care for Individuals with Opioid Use Disorder

Law & Policy InsightsCOVID-19Harm Reduction Legal ProjectHarm Reduction Legal Project ResourcesSubstance Use Prevention and Harm Reduction

October 6, 2020
by Amy Lieberman and Corey Davis

In this Q&A, Corey Davis, deputy director of the Network’s Southeastern Region Office and director of the Network’s Harm Reduction Legal Project; and Amy Lieberman, senior attorney, for the Network’s Harm Reduction Legal Project, discuss some of the key elements in the chapter they authored, Access to Care for Individuals with Opioid Use Disorder, for the Report.

Read more

Legality of Dispensing and Administering Expired Naloxone in Georgia

Fact SheetSubstance Use Prevention and Harm ReductionHarm Reduction Legal Project ResourcesHarm Reduction Legal ProjectOpioid Misuse and Overdose Prevention

June 4, 2020
by Amy Lieberman and Corey Davis

While states have passed various laws designed to increase access to naloxone, a life-saving opioid overdose reversal medication, none explicitly address the legality of dispensing naloxone that is past its expiration date. This fact sheet discusses whether Georgia laws forbid the prescription, dispensing, distribution, possession, or administration of expired naloxone and whether such actions impact the risk of civil liability for medical professionals who prescribe or dispense naloxone or laypeople who distribute or administer it.

View page

Legality of Dispensing and Administering Expired Naloxone in the District of Columbia

Fact SheetSubstance Use Prevention and Harm ReductionHarm Reduction Legal Project ResourcesHarm Reduction Legal ProjectOpioid Misuse and Overdose Prevention

May 21, 2020
by Amy Lieberman and Corey Davis

This fact sheet discusses whether District of Columbia laws forbid the prescription, dispensing, distribution, possession, or administration of expired naloxone and whether such actions impact the risk of civil liability for medical professionals who prescribe or dispense naloxone or laypeople who distribute or administer it.

View page